Treatment options for hepatobiliary and pancreatic cancer

Steven Robert Alberts, Gregory James Gores, George P. Kim, Lewis Rowland Roberts, Michael L. Kendrick, Charles B. Rosen, Suresh T Chari, James A. Martenson

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Hepatobiliary and pancreatic cancers account for 4% of all cancers in the United States. Traditionally, these cancers have had a high mortality rate and have been poorly responsive to therapy. Because of a growing number of treatment options, patients are now living longer. For hepatocellular carcinoma, a broad number of treatment options are available, including surgery, ablation, embolization, systemic therapy, and liver transplantation. Treatment options for cholangiocarcinoma include surgery, systemic therapy, and liver transplantation. For pancreatic cancer, surgery, radiation, and systemic therapy all have potential roles. This review provides an updated summary of diagnosis and assessment together with treatment options for this group of cancers.

Original languageEnglish (US)
Pages (from-to)628-637
Number of pages10
JournalMayo Clinic Proceedings
Volume82
Issue number5
DOIs
StatePublished - 2007

Fingerprint

Pancreatic Neoplasms
Liver Transplantation
Therapeutics
Neoplasms
Cholangiocarcinoma
Hepatocellular Carcinoma
Radiotherapy
Mortality

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Treatment options for hepatobiliary and pancreatic cancer. / Alberts, Steven Robert; Gores, Gregory James; Kim, George P.; Roberts, Lewis Rowland; Kendrick, Michael L.; Rosen, Charles B.; Chari, Suresh T; Martenson, James A.

In: Mayo Clinic Proceedings, Vol. 82, No. 5, 2007, p. 628-637.

Research output: Contribution to journalArticle

Alberts, Steven Robert ; Gores, Gregory James ; Kim, George P. ; Roberts, Lewis Rowland ; Kendrick, Michael L. ; Rosen, Charles B. ; Chari, Suresh T ; Martenson, James A. / Treatment options for hepatobiliary and pancreatic cancer. In: Mayo Clinic Proceedings. 2007 ; Vol. 82, No. 5. pp. 628-637.
@article{426876f8f9e7412a805bd49b66395b6c,
title = "Treatment options for hepatobiliary and pancreatic cancer",
abstract = "Hepatobiliary and pancreatic cancers account for 4{\%} of all cancers in the United States. Traditionally, these cancers have had a high mortality rate and have been poorly responsive to therapy. Because of a growing number of treatment options, patients are now living longer. For hepatocellular carcinoma, a broad number of treatment options are available, including surgery, ablation, embolization, systemic therapy, and liver transplantation. Treatment options for cholangiocarcinoma include surgery, systemic therapy, and liver transplantation. For pancreatic cancer, surgery, radiation, and systemic therapy all have potential roles. This review provides an updated summary of diagnosis and assessment together with treatment options for this group of cancers.",
author = "Alberts, {Steven Robert} and Gores, {Gregory James} and Kim, {George P.} and Roberts, {Lewis Rowland} and Kendrick, {Michael L.} and Rosen, {Charles B.} and Chari, {Suresh T} and Martenson, {James A.}",
year = "2007",
doi = "10.4065/82.5.628",
language = "English (US)",
volume = "82",
pages = "628--637",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "5",

}

TY - JOUR

T1 - Treatment options for hepatobiliary and pancreatic cancer

AU - Alberts, Steven Robert

AU - Gores, Gregory James

AU - Kim, George P.

AU - Roberts, Lewis Rowland

AU - Kendrick, Michael L.

AU - Rosen, Charles B.

AU - Chari, Suresh T

AU - Martenson, James A.

PY - 2007

Y1 - 2007

N2 - Hepatobiliary and pancreatic cancers account for 4% of all cancers in the United States. Traditionally, these cancers have had a high mortality rate and have been poorly responsive to therapy. Because of a growing number of treatment options, patients are now living longer. For hepatocellular carcinoma, a broad number of treatment options are available, including surgery, ablation, embolization, systemic therapy, and liver transplantation. Treatment options for cholangiocarcinoma include surgery, systemic therapy, and liver transplantation. For pancreatic cancer, surgery, radiation, and systemic therapy all have potential roles. This review provides an updated summary of diagnosis and assessment together with treatment options for this group of cancers.

AB - Hepatobiliary and pancreatic cancers account for 4% of all cancers in the United States. Traditionally, these cancers have had a high mortality rate and have been poorly responsive to therapy. Because of a growing number of treatment options, patients are now living longer. For hepatocellular carcinoma, a broad number of treatment options are available, including surgery, ablation, embolization, systemic therapy, and liver transplantation. Treatment options for cholangiocarcinoma include surgery, systemic therapy, and liver transplantation. For pancreatic cancer, surgery, radiation, and systemic therapy all have potential roles. This review provides an updated summary of diagnosis and assessment together with treatment options for this group of cancers.

UR - http://www.scopus.com/inward/record.url?scp=34248146165&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248146165&partnerID=8YFLogxK

U2 - 10.4065/82.5.628

DO - 10.4065/82.5.628

M3 - Article

VL - 82

SP - 628

EP - 637

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 5

ER -